OakChart

Staar Surgical Co

STAAHealthcare·Medical Instruments & Supplies·USA·Small·NASD·Nov 11 • 1:27 PM ET

26.00+2.12 (8.90%)
2026-11-11 19:27 CET
Market cap
1,198.32 USD m
Revenue, TTM
328.27 USD m
Net income, TTM
0.53 USD m
Free cash flow, TTM
17.85 USD m
EPS diluted, TTM
-0.00
P/E
-
Compare

Price

STAA against its 20, 50 and 200-day averages
2050200beat
20.0025.0030.0035.002.9M5.7MMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26STAAclose 26.0020-day 23.9950-day 22.83200-day 23.8226.0052w high

27.5% under the 52-week high of 35.87 on 14 May 2026. 52-week low 15.59 on 17 Feb 2026. Last 15 sessions, 36.8% high to low

Profile

STAA
52-week range, 51% of the way up
15.5935.87

STAAR Surgical Co. engages in the design, development, manufacture, and sale of ophthalmic surgical products. The firm offers implantable lenses for the eye and accessory delivery systems. Its products include refractive and cataract solutions through the Collamer brand. The company was founded in 1982 and is headquartered in Lake Forest, CA.

IndexRUT
Employees957
IPOJul 07, 1983
Beta1.20
ATR, 14d1.35
Rel volume0.81
Short float12.02%
Insider own39.53%
Inst own71.90%

Snapshot

6 groups

Valuation

IndexRUT
Market Cap1.30B
Enterprise Value1.13B
Income0.53M
Sales328.27M
Book/sh7.49
Cash/sh4.11
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout-
Employees957
IPOJul 07, 1983

Ratios

P/E-
Forward P/E44.44
PEG-
P/S3.98
P/B3.47
P/C6.32
P/FCF73.11
EV/EBITDA34.19
EV/Sales3.45
Quick Ratio4.08
Current Ratio4.68
Debt/Eq0.09
LT Debt/Eq0.07
Option/ShortYes / Yes

Earnings

EPS (ttm)-0.00
EPS next Y0.58
EPS next Q-0.05
EPS this Y134.59%
EPS next Y69.11%
EPS next 5Y-
EPS past 3/5Y- -
Sales past 3/5Y-5.57% 7.93%
EPS Y/Y TTM100.35%
Sales Y/Y TTM42.36%
EPS Q/Q-38.34%
Sales Q/Q-11.95%
EarningsNov 04 AMC
EPS/Sales Surpr.116.96% 5.94%

Ownership

Insider Own39.53%
Insider Trans0.00%
Inst Own71.90%
Inst Trans-6.36%
ROA0.11%
ROE0.15%
ROIC0.13%
Gross Margin71.27%
Oper. Margin6.73%
Profit Margin0.16%
SMA208.35%
SMA5013.87%
SMA2009.14%
Trades-

Technical

Shs Outstand50.20M
Shs Float30.36M
Short Float12.02%
Short Ratio4.03
Short Interest3.65M
52W High35.87 -27.53%
52W Low15.59 66.80%
Volatility7.83% 4.93%
ATR (14)1.35
RSI (14)59.87
Beta1.20
Rel Volume0.81
Avg Volume906.07K
Volume460,024

Performance

Perf Week-4.32%
Perf Month20.91%
Perf Quarter2.63%
Perf Half Y-11.58%
Perf YTD12.58%
Perf Year-5.13%
Perf 3Y-22.38%
Perf 5Y-77.02%
Perf 10Y145.24%
Recom2.60
Target Price29.25
Prev Close23.87
Price26.00
Change %8.90%

Analyst ratings

latest 10 of 20
DateActionAnalystRating changeTargetImplied
Sep 29, 2026UpgradeSStifelHold → Buy$31+19.3%
Jul 28, 2026InitiatedUUBSSell$20-23.1%
May 14, 2026UpgradeWWedbushNeutral → Outperform$40+53.9%
Apr 09, 2026UpgradeCCanaccord GenuityHold → Buy$27+3.9%
Feb 03, 2026InitiatedWWedbushNeutral$260.0%
Jan 16, 2026ResumedMMorgan StanleyUnderweight$13-50.0%
Apr 21, 2025InitiatedWWells FargoEqual Weight$17-34.6%
Feb 12, 2025DowngradeWWilliam BlairOutperform → Mkt Perform
Feb 12, 2025DowngradeMMizuhoOutperform → Neutral$45 → $17-34.6%
Feb 12, 2025DowngradeJJefferiesBuy → Hold

Peers

Mkt cap
TickerCompanyMkt cap
ALCAlcon Inc34.69B
BLCOBausch + Lomb Corp7.62B
RXSTRxSight Inc209.64M
COOCooper Companies Inc11.94B
GKOSGlaukos Corp14.58B
WRBYWarby Parker Inc3.91B
SGHTSight Sciences Inc604.42M
ESTAEstablishment Labs Holdings Inc2.12B
INMDInmode Ltd775.98M
LNSRLENSAR Inc53.87M

Insider trading

latest 14 of 22
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
ANDREWS DEBORAH JChief Financial Officer & EVPAug 14 '26Option Exercise0.005,233041,452Aug 18 04:03 PM
Foust WarrenPresident and CEOAug 14 '26Option Exercise0.0010,997093,951Aug 18 04:03 PM
Michna MagdaChief Development OfficerAug 14 '26Option Exercise4.366,59928,79843,599Aug 18 04:03 PM
Butcher Arthur CDirectorJun 18 '26Option Exercise0.005,34109,549Jun 22 04:05 PM
SILVERMAN LOUDirectorJun 18 '26Option Exercise0.0010,683011,158Jun 22 04:05 PM
Jiang WeiDirectorJun 18 '26Option Exercise0.0010,683077,127Jun 22 04:05 PM
Foust WarrenInterim Co-CEO and Pres. & COOMar 14 '26Option Exercise0.0029,325063,588Mar 16 05:00 PM
Foust WarrenInterim Co-CEO and Pres. & COOMar 12 '26Option Exercise0.008,175034,263Mar 16 05:00 PM
Michna MagdaChief Development OfficerMar 14 '26Option Exercise0.0017,595036,001Mar 16 05:00 PM
Michna MagdaChief Development OfficerMar 12 '26Option Exercise0.006,178020,622Mar 16 05:00 PM
BROADWOOD PARTNERS, L.P.DirectorMar 13 '26Buy18.61316,0175,882,65616,123,842Mar 13 07:59 PM
BROADWOOD PARTNERS, L.P.DirectorMar 12 '26Buy18.12299,4325,424,33015,807,825Mar 13 07:59 PM
BROADWOOD PARTNERS, L.P.DirectorMar 11 '26Buy17.5254,764959,55815,508,393Mar 13 07:59 PM
Jiang WeiDirectorJan 12 '26Option Exercise0.0020,967066,444Jan 14 05:48 PM

Held by

AUM
TickerCompanyAUM
IJRiShares Core S&P Small-Cap ETFAUM: 106.27B
VTIVanguard Morningstar Total Stock Market ETFAUM: 687.42B
IWMiShares Russell 2000 Index FundAUM: 77.38B
VBVanguard Morningstar Small-Cap ETFAUM: 79.59B
VBKVanguard Morningstar Small-Cap Growth ETFAUM: 22.34B
VXFVanguard Extended Market Index ETFAUM: 30.47B
DFASU.S. Small Cap Portfolio-ETF Class Shares-
SPSMState Street SPDR Portfolio S&P 600TM Small Cap ETFAUM: 16.06B
IWOiShares Russell 2000 Growth ETFAUM: 14.06B
DFMCU.S. Micro Cap Portfolio ETF Class Shares-

News

latest 14 of 200

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-11-040.1100.0510.11083.4178.7410
2026Q22026-08-120.1600.2210.15793.5490.6010
2026Q12026-05-130.4100.0540.10293.5278.729
2025Q42026-03-03-0.2000.180-0.36857.8074.965
2025Q32025-11-050.3400.2460.17694.7394.707
2025Q22025-08-06-0.340-0.561-0.34044.3240.509
2025Q12025-05-07-0.517-0.603-1.09942.5940.3410
2024Q42025-02-11-0.514-0.027-0.69548.9577.2210
2024Q32024-10-300.2600.1800.20188.5986.907
2024Q22024-08-070.3900.2390.14899.0195.229
2024Q12024-05-070.1070.061-0.06877.3675.348
2023Q42024-02-260.1300.1790.15876.2775.949
2023Q32023-11-010.3000.1630.09880.3180.3710
2023Q22023-08-020.4000.2800.12392.3192.5112
2023Q12023-05-030.1800.0740.05573.5366.2311
2022Q42023-02-210.1400.1350.11964.0464.129

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2019FY0.4600.4200.300150.19149.73
2020FY0.3500.2980.123163.46161.74
2021FY0.8700.8430.495230.47230.96
2022FY1.2201.2150.803284.39284.45
2023FY1.0101.0430.432322.42322.11
2024FY0.2150.693-0.411313.9342.47
2025FY-1.0000.023-1.620239.44256.29
2026FY-0.346--339.75
2027FY-0.585--370.09
2028FY-0.718--401.85
2029FY-0.893--454.68
2030FY-1.077--501.07

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q4S2026-11-05104269.0063.5275.30
2026Q4S2026-11-04101068.4062.2574.90
2026Q4S2026-10-27101068.4062.2574.90
2026Q4S2026-10-12103568.4062.2574.90
2026Q4S2026-10-09103568.4062.2574.90
2026Q4S2026-10-01103568.3962.2574.90
2026Q4S2026-09-28113568.4662.2574.90
2026Q4S2026-09-23113568.3462.2574.90
2026Q4S2026-08-19113568.3462.2574.90
2026Q4S2026-08-14113568.3462.2574.90
2026Q4S2026-08-13112568.2762.2574.90
2026Q4S2026-07-28110069.1962.6078.50
2026Q4S2026-07-27115269.1962.6078.50
2026Q4S2026-07-16105269.2062.6078.50

Estimate history

EPS, annual-0.0520.110.30.1230.4950.8030.432-0.411-1.623-0.0009
Period201720182019202020212022202320242025TTM
EPS, quarterly0.201-0.695-1.099-0.340.176-0.3680.1020.1570.108
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Sales, annual90.611123.954150.185163.46230.472284.391322.415313.901239.442328.27
Period201720182019202020212022202320242025TTM
Sales, quarterly88.5948.9542.58944.3294.73257.80193.52293.53583.411
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Shares, annual41.38344.19544.82246.44847.71648.21248.83949.29449.40350.201
Period201720182019202020212022202320242025MRQ
Shares, quarterly49.27149.29449.52349.28549.35449.40349.40450.12350.201
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue328.27239.44313.90322.42284.39230.47163.46150.19123.95
Cost of Goods Sold Incl. D&A94.3062.5578.5569.7661.0151.8443.9038.2332.44
Gross Profit233.97176.90235.36252.65223.38178.64119.56111.9591.51
Selling, General and Administrative Excl. Other211.89222.84247.98224.72179.64145.30111.71100.1084.92
Research and Development38.7939.2853.2944.4035.9833.8631.9225.3022.03
Other Operating Expense0.00-0.07-0.01-0.17-0.06-0.01-0.120.000.00
Operating Income22.08-45.87-12.6128.1043.8033.347.9711.856.59
Interest Expense-----0.04---
Unusual Expense21.3345.770.000.000.000.001.20--
Net Income Before Taxes5.57-82.26-9.0533.7045.5531.308.2713.036.64
Income Taxes5.04-1.8111.1612.355.896.802.35-1.021.67
Consolidated Net Income0.53-80.45-20.2121.3539.6624.505.9114.054.97
Net Income From Continuing Operations0.53-80.45-20.2121.3539.6624.505.9114.054.97
Net Income0.53-80.45-20.2121.3539.6624.505.9114.054.97
EPS (Recurring)0.30-0.98-0.410.430.800.500.140.300.11
EPS (Basic, Before Extraordinaries)0.01-1.62-0.410.440.830.520.130.320.12
EPS (Diluted)-0.00-1.62-0.410.430.800.500.120.300.11
EBITDA33.12-37.18-5.7233.2248.3136.9811.0615.559.06
Non-Operating Income (Expense)4.829.383.565.601.75-2.001.501.170.04
Other After Tax Adjustments0.000.000.000.000.000.000.000.000.00
Stock Option Compensation Expense21.3124.1621.5018.5816.0914.618.877.705.34
Price To Earnings Ratio--55.4479.3563.34184.30659.62117.39289.56
Price To Sales Ratio3.524.893.794.788.4319.5923.2410.7411.41
Gross Margin71.2773.8874.9878.3678.5577.5173.1474.5473.83
Operating Margin6.73-19.16-4.028.7115.4014.474.887.895.32
Net Margin0.16-33.60-6.446.6213.9510.633.629.354.01
Shares Outstanding50.2049.4049.2948.8448.2147.7246.4544.8244.20
Market Capitalization1,198.321,198.321,196.911,523.592,339.934,345.913,652.821,566.581,408.25

Income statement, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q22025Q12024Q4
Total Revenue83.4193.5393.5257.8094.7344.3242.5948.95
Cost of Goods Sold Incl. D&A26.7026.2126.0015.3918.1112.7216.0217.30
Gross Profit56.7167.3267.5242.4176.6231.6026.5731.65
Selling, General and Administrative Excl. Other51.2557.2250.1253.2932.1356.3183.9759.56
Research and Development10.269.779.729.049.0110.0713.4812.04
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income5.4610.1017.40-10.8844.49-24.72-57.40-27.91
Unusual Expense0.000.009.4211.9026.005.250.000.00
Net Income Before Taxes6.9811.028.22-20.6518.79-25.91-54.49-30.33
Income Taxes1.412.973.01-2.349.91-9.10-0.283.89
Consolidated Net Income5.588.065.21-18.318.88-16.81-54.21-34.23
Net Income From Continuing Operations5.588.065.21-18.318.88-16.81-54.21-34.23
Net Income5.588.065.21-18.318.88-16.81-54.21-34.23
EPS (Recurring)0.110.160.23-0.200.54-0.27-1.10-0.69
EPS (Basic, Before Extraordinaries)0.110.160.10-0.370.18-0.34-1.10-0.69
EPS (Diluted)0.110.160.10-0.370.18-0.34-1.10-0.69
EBITDA8.8413.4419.61-8.7746.49-22.74-55.06-25.54
Non-Operating Income (Expense)1.520.920.242.130.304.052.92-2.42
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense5.525.183.816.806.446.164.753.69
Price To Earnings Ratio-------55.44
Price To Sales Ratio3.524.213.544.905.873.733.143.80
Gross Margin67.9971.9872.2073.3780.8971.2962.3964.65
Operating Margin6.5410.8018.61-18.8346.96-55.77-134.78-57.02
Net Margin6.688.615.57-31.689.38-37.93-127.29-69.92
Shares Outstanding50.2050.1249.4049.4049.3549.2849.5249.29
Market Capitalization1,198.321,428.43925.891,148.541,326.14831.05869.611,196.91

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY
Cash & Short Term Investments187.54230.49220.73211.64199.71152.45119.97103.8818.52
Short Term Receivables54.6179.2797.9865.9846.6138.7032.5927.7219.50
Inventories55.5043.3035.1324.1617.2718.1117.1416.7013.31
Other Current Assets13.9114.8811.439.957.827.164.973.272.56
Total Current Assets311.55367.94365.27311.72271.41216.42174.67151.5753.89
Net Property, Plant & Equipment102.93121.78101.4181.5367.7333.3925.6211.459.78
Total Investments and Advances0.000.0011.7013.900.000.000.000.120.12
Intangible Assets32.491.791.791.962.002.062.082.032.06
Deferred Tax Assets13.310.795.198.743.814.944.411.281.24
Other Assets1.3517.233.340.960.820.610.750.890.85
Total Assets461.62509.52488.69418.82345.78257.42207.52167.3467.93
Short Term Debt Incl. Current Port. of LT Debt5.873.944.373.693.414.225.094.885.72
Accounts Payable11.5716.7013.5611.588.707.878.056.526.03
Income Tax Payable1.306.5510.853.852.254.662.712.100.66
Other Current Liabilities49.7543.1236.2632.6034.4524.4818.6314.236.68
Total Current Liabilities68.5070.3165.0451.7248.8041.2434.4827.7319.09
Long Term Debt32.4834.8131.4727.3528.656.584.450.460.53
Provision for Risks Charges6.426.785.162.158.9612.168.055.524.86
Deferred Tax Liabilities9.940.301.081.490.810.220.661.020.35
Other Liabilities0.090.000.000.000.000.000.000.190.17
Total Liabilities117.44112.19102.7482.7187.2260.1947.6434.9125.00
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.000.00
Common Equity344.18397.33385.95336.11258.56197.22159.88132.4342.94
Total Shareholders Equity344.18397.33385.95336.11258.56197.22159.88132.4342.94
Accumulated Minority Interest0.000.000.000.000.000.000.000.000.00
Total Equity344.18397.33385.95336.11258.56197.22159.88132.4342.94
Total Liabilities & Stockholders Equity461.62509.52488.69418.82345.78257.42207.52167.3467.93
Book Value Per Share6.978.067.906.975.424.253.573.001.04
Tangible Book Value Per Share6.318.027.876.935.384.203.522.950.99
Full-Time Employees9571,2111,115964806575550475353
Price to Book Ratio3.192.804.027.3116.8518.669.8610.6515.69
Return on Assets-16.57-4.054.7210.388.122.557.504.22-3.21
Return on Equity-21.70-5.165.9513.3410.753.319.615.67-5.29
Return on Invested Capital-21.36-4.685.1110.918.532.908.553.74-4.92
Quick Ratio3.744.625.085.565.214.814.574.862.13
Current Ratio4.555.235.626.035.565.255.075.472.82

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income0.53-80.45-20.2121.3539.6624.505.9114.054.97
Depreciation11.358.736.895.124.513.643.103.702.46
Other Funds (Non Cash)38.2056.7330.8525.7022.6716.7215.5612.789.38
Funds from Operations50.32-17.9021.1355.4364.5946.3523.7127.0417.25
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital-28.92-16.33-5.40-40.84-28.88-2.39-2.76-1.25-4.49
Cash from Operating Activities21.40-34.2315.7214.5935.7243.9620.9525.8012.77
Capital Expenditures-3.55-5.82-23.39-18.19-18.11-13.64-8.40-10.18-2.25
Net Assets From Acquisitions0.000.000.000.000.000.000.000.00-
Sale of Fixed Assets and Businesses0.000.000.000.000.000.000.000.00-
Purchase or Sale of Investments-55.7552.16-35.8292.53-138.270.000.000.000.00
Purchase of Investments-130.85-75.36-80.24-52.31-155.750.000.000.000.00
Sale Or Maturity of Investments75.09127.5244.42144.8517.480.000.000.000.00
Other Uses0.000.000.000.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.000.000.000.00
Cash from Investing Activities-59.3046.34-59.2274.35-156.38-13.64-8.40-10.18-2.25
Cash Dividends Paid0.000.000.000.000.000.000.000.000.00
Change in Capital Stock-4.40-2.995.897.588.4219.4420.653.4677.29
Repurchase of Common Pref Stock-5.93-6.46-1.50-2.100.000.000.000.00-0.05
Sale of Common Pref Stock1.533.477.399.678.4219.4420.653.4677.35
Proceedsfrom Stock Options0.000.000.000.000.000.000.000.0072.15
Issuance or Reduction of Debt, Net0.00-0.04-0.17-0.16-0.13-1.65-1.08-3.31-2.65
Change in Long Term Debt0.00-0.04-0.17-0.16-0.13-0.35-0.56-1.29-1.91
Issuance of Long Term Debt0.000.000.000.000.000.000.000.000.00
Reduction of Long Term Debt0.00-0.04-0.17-0.16-0.13-0.35-0.56-1.29-1.91
Net Financing Active Other Cash Flow-0.16-1.520.000.000.000.000.000.000.00
Other Financing Activities Uses-0.16-1.520.000.000.000.000.000.000.00
Cash from Financing Activities-4.56-4.555.727.428.3017.7919.570.1574.64
Exchange Rate Effect-0.071.44-1.110.20-0.86-0.860.370.200.20
Net Change in Cash-42.558.99-38.8896.56-113.2347.2532.4815.9785.36
Free Cash Flow17.85-40.05-7.67-3.5917.6130.3212.5515.7010.52
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.000.000.00
Price to Free Cash Flow64.78---136.13148.94302.77102.69134.45
Deferred Taxes & Investment Tax Credit--2.923.593.26-2.251.50-0.85-3.480.44

Balance sheet, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Cash & Short Term Investments206.41181.49163.89187.54192.66189.88
Short Term Receivables90.37102.0685.6954.6163.5737.08
Inventories45.0246.8449.7855.5053.3053.11
Other Current Assets11.6311.9713.0313.9111.6812.72
Total Current Assets353.43342.35312.40311.55321.21292.79
Net Property, Plant & Equipment94.6997.44100.31102.93103.94107.44
Total Investments and Advances0.000.000.000.000.000.00
Intangible Assets34.8533.1036.0532.491.791.79
Deferred Tax Assets1.031.091.0913.311.9811.89
Other Assets1.161.231.271.3527.4523.87
Total Assets485.16475.20451.12461.62456.36437.78
Short Term Debt Incl. Current Port. of LT Debt5.946.186.105.875.315.10
Accounts Payable14.2513.488.7011.579.1812.35
Income Tax Payable3.382.14-1.301.081.07
Other Current Liabilities51.9651.6046.2049.7546.0640.71
Total Current Liabilities75.5473.3960.9968.5061.6459.23
Long Term Debt27.7029.7731.1932.4833.8035.42
Provision for Risks Charges5.706.566.486.427.056.56
Deferred Tax Liabilities---9.94--
Other Liabilities0.090.090.090.090.090.00
Total Liabilities109.03109.8198.75117.44102.58101.21
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity376.13365.40352.37344.18353.78336.57
Total Shareholders Equity376.13365.40352.37344.18353.78336.57
Accumulated Minority Interest0.000.000.000.000.000.00
Total Equity376.13365.40352.37344.18353.78336.57
Total Liabilities & Stockholders Equity485.16475.20451.12461.62456.36437.78
Book Value Per Share7.497.297.136.977.176.83
Tangible Book Value Per Share6.806.636.406.317.136.79
Full-Time Employees---957--
Price to Book Ratio3.194.022.683.223.932.37
Return on Assets0.110.84-4.63-16.57-19.39-20.05
Return on Equity0.151.09-5.99-21.70-24.65-25.55
Return on Invested Capital1.382.041.36-4.862.29-4.52
Quick Ratio4.084.034.313.744.354.05
Current Ratio4.684.665.124.555.214.94

Cash flow, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Net Income5.588.065.21-18.318.88-16.81
Depreciation3.383.342.212.422.001.98
Other Funds (Non Cash)3.5310.6510.7713.2512.6613.05
Funds from Operations11.7922.3720.99-4.8433.45-11.38
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital15.53-2.68-42.690.92-30.79-15.87
Cash from Operating Activities27.3219.69-21.70-3.912.67-27.25
Capital Expenditures-0.94-0.49-0.44-1.68-0.88-1.79
Net Assets From Acquisitions0.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.00
Purchase or Sale of Investments-39.73-0.872.59-17.746.1726.91
Purchase of Investments-49.20-28.23-4.52-48.90-11.770.00
Sale Or Maturity of Investments9.4727.367.1131.1617.9426.91
Other Uses0.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.00
Cash from Investing Activities-40.67-1.372.15-19.415.2825.12
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock-1.32-1.50-1.690.110.98-4.47
Repurchase of Common Pref Stock-1.32-2.74-1.870.00-1.98-4.48
Sale of Common Pref Stock0.001.240.170.112.960.01
Proceedsfrom Stock Options0.000.000.000.000.000.00
Issuance or Reduction of Debt, Net0.000.000.000.000.000.00
Change in Long Term Debt0.000.000.000.000.000.00
Issuance of Long Term Debt0.000.000.000.000.000.00
Reduction of Long Term Debt0.000.000.000.000.000.00
Net Financing Active Other Cash Flow0.000.000.00-0.160.00-0.07
Other Financing Activities Uses0.000.000.00-0.160.00-0.07
Cash from Financing Activities-1.32-1.50-1.69-0.050.98-4.54
Exchange Rate Effect-0.30-0.11-0.040.370.090.69
Net Change in Cash-14.9716.71-21.29-23.009.02-5.98
Free Cash Flow26.3819.20-22.14-5.591.78-29.04
Price to Free Cash Flow64.78-----

Revenue breakdown

Total Ophthalmic Goods revenue2024: 313.90M 2025: 239.44M
United States2024: 313.90M 2025: 239.44M

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-3012.02%3.6M30.4M892.89K
2026-10-1512.19%3.7M30.3M995.22K
2026-09-3012.33%3.7M30.3M1.01M
2026-09-1515.27%4.6M30.3M900.70K
2026-08-3114.13%4.3M30.2M833.55K
2026-08-1414.55%4.4M30.2M880.24K
2026-07-3116.60%5.0M30.0M897.28K
2026-07-1516.99%5.1M30.0M814.38K
2026-06-3017.61%5.3M30.0M965.46K
2026-06-1516.83%5.1M30.0M1.09M
2026-05-2917.50%5.2M29.9M1.20M
2026-05-1519.70%5.9M29.9M1.32M
2026-04-3020.41%6.7M33.0M1.33M
2026-04-1515.26%7.5M49.1M1.42M
2026-03-3115.72%7.7M49.2M1.52M
2026-03-1314.27%7.0M49.2M1.48M
2026-02-2712.66%6.2M49.2M1.54M
2026-02-1311.61%5.7M49.4M1.39M
2026-01-308.12%4.0M49.3M1.33M
2026-01-158.18%4.0M49.3M1.34M

Option chain

expiry 2026-11-20
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call12.5011.3013.600.002.8480.000.000.986-0.0190.001
call15.008.8011.200.002.7000.000.000.982-0.0190.002
call17.506.308.708.862.0693.000.000.977-0.0180.002
call20.003.806.304.021.63191.000.000.920-0.0440.006
call22.502.153.906.301.17279.000.000.880-0.0380.008
call25.001.101.550.900.6862701.000.638-0.0610.015
call27.500.250.500.450.66587.000.000.376-0.0830.015
call30.000.100.150.100.74134017.000.109-0.0320.008
call32.500.002.100.061.01221.000.000.085-0.0360.006
put12.500.000.550.002.2830.000.00-0.014-0.0180.001
put15.000.000.050.001.4910.000.00-0.021-0.0150.002
put17.500.000.050.151.0551390.00-0.029-0.0140.003
put20.000.000.250.151.25154.000.00-0.080-0.0420.006
put22.500.050.200.150.81036.005.00-0.118-0.0360.008
put25.000.500.751.500.73131.001.00-0.347-0.0580.015
put27.501.604.302.032.0645.000.00-0.635-0.0770.015
put30.004.006.300.002.2480.000.00-0.890-0.0280.008
put32.506.408.800.002.6330.000.00-0.915-0.0320.006

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-0410-QQuarterly report pursuant to Section 13 or 15(d)2026-10-02SEC
2026-11-048-KCurrent report2026-11-04SEC
2026-10-27SCHEDULE 13G/ASEC
2026-10-058-K/A2026-09-08SEC
2026-09-108-KCurrent report2026-09-09SEC
2026-08-184Statement of changes in beneficial ownership of securities2026-08-14SEC
2026-08-184Statement of changes in beneficial ownership of securities2026-08-14SEC
2026-08-184Statement of changes in beneficial ownership of securities2026-08-14SEC
2026-08-14SCHEDULE 13G/ASEC
2026-08-1210-QQuarterly report pursuant to Section 13 or 15(d)2026-07-03SEC
2026-08-128-KCurrent report2026-08-12SEC
2026-08-068-KCurrent report2026-08-05SEC
2026-08-044Statement of changes in beneficial ownership of securities2026-07-31SEC
2026-08-044Statement of changes in beneficial ownership of securities2026-06-25SEC
2026-06-24S-8Initial registration statement for securities to be offered to employees pursuant to employee benefit plansSEC
2026-06-234Statement of changes in beneficial ownership of securities2026-06-18SEC
2026-06-224Statement of changes in beneficial ownership of securities2026-06-18SEC
2026-06-224Statement of changes in beneficial ownership of securities2026-06-18SEC
2026-06-224Statement of changes in beneficial ownership of securities2026-06-18SEC
2026-06-224Statement of changes in beneficial ownership of securities2026-06-18SEC
2026-06-224Statement of changes in beneficial ownership of securities2026-06-18SEC
2026-06-224Statement of changes in beneficial ownership of securities2026-06-18SEC
2026-06-228-KCurrent report2026-06-18SEC
2026-06-154Statement of changes in beneficial ownership of securities2026-06-12SEC
2026-06-098-KCurrent report2026-06-09SEC
2026-05-194Statement of changes in beneficial ownership of securities2026-05-15SEC
2026-05-194Statement of changes in beneficial ownership of securities2026-05-15SEC
2026-05-194Statement of changes in beneficial ownership of securities2026-05-15SEC
2026-05-1310-QQuarterly report pursuant to Section 13 or 15(d)2026-04-03SEC
2026-05-138-KCurrent report2026-05-12SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-090000
2026-080000
2026-070000
2026-060000
2026-050000
2026-040000
2026-0312.27M300
2026-020000
2026-019.42M400
2025-120000
2025-1141.06M300

Institutional holders

Manager% owned
BROADWOOD CAPITAL INC32.38%
BlackRock, Inc.13.52%
Madison Avenue Partners, LP8.39%
Yunqi Capital Ltd6.50%
Point72 Asset Management, L.P.4.90%
GOLDMAN SACHS GROUP INC4.32%
VANGUARD PORTFOLIO MANAGEMENT LLC3.98%
STATE STREET CORP3.55%
Anatole Investment Management Ltd3.32%
VANGUARD CAPITAL MANAGEMENT LLC3.12%

Funds

Fund% owned
WisdomTree Emerging Markets High Dividend Fund84.27%
WisdomTree Emerging Markets SmallCap Dividend Fund32.41%
Avantis Emerging Markets Equity ETF10.90%
iShares Core S&P Small-Cap ETF6.03%
VANGUARD TOTAL STOCK MARKET INDEX FUND1.91%
iShares Russell 2000 ETF1.77%
VANGUARD SMALL-CAP INDEX FUND1.38%
VANGUARD EXTENDED MARKET INDEX FUND1.15%
State Street(R) SPDR(R) Portfolio S&P 600(TM) Small Cap ETF0.92%
VANGUARD SMALL-CAP GROWTH INDEX FUND0.79%

OakChart. STAA. Cached 15 minutes.